Main, New Mountain, Marlin Equity target patient engagement tech; Specialty pharmacy, mental health needs drive Flexpoint’s sale of ArtesRx
New software, including agentic AI applications, are fueling provider adoption of patient engagement technology, and PE dealmakers see opportunities to scale these capabilities further; exploring Flexpoint Ford's sale of ArtesRx, a behavioral health pharmacy, to Linden Capital…
New software, including agentic AI applications, are fueling provider adoption of patient engagement technology, and PE dealmakers see opportunities to scale these capabilities further; exploring Flexpoint Ford's sale of ArtesRx, a behavioral health pharmacy, to Linden Capital…
BELLINGS Intelligence Score: 12
Why it matters
This event describes private equity targeting patient engagement technology and a sale in specialty pharmacy, which are routine dealmaking activities within the PE sector without novel structures or systemic implications.
Sources
PE Hub
Main, New Mountain, Marlin Equity target patient engagement tech; Specialty pharmacy, mental health needs drive Flexpoint’s sale of ArtesRx
New software, including agentic AI applications, are fueling provider adoption of patient engagement technology, and PE dealmakers see opportunities to scale these capabilities further; exploring Flexpoint Ford's sale of ArtesRx, a behavioral health pharmacy, to Linden Capital…